El árbol tropical Calophyllum brasiliense: una revisión botánica, química y farmacéutica
DOI:
https://doi.org/10.17533/udea.vitae.15477Keywords:
Calophyllum brasiliense, cumarinas, VIH/SIDA, Trypanosoma, LeishmaniaAbstract
Antecedentes: Calophyllum brasiliense Cambess. Es un árbol de la familia Calophyllaceae, separada recientemente de Clusiaceae (Guttiferae). Se distribuye ampliamente en selvas tropicales lluviosas del continente americano, desde Brasil hasta México. Esta especie sintetiza diversos metabolitos secundarios en hojas, flores, frutos, corteza y raíz, tales como cumarinas, cromanonas, xantonas, terpenos, flavonoides y compuestos fenólicos, los cuales presentan múltiples propiedades biológicas. Objetivos: Ofrecer una visión general de las características botánicas, químicas y farmacológicas de C. brasiliense, así como evidencias químicas, anatómicas y genéticas que sugieren la existencia de quimiotipos (fenotipos químicos) en la especie. Métodos: Se revisó la información disponible en las bases de datos NCBI y SciFinder®, se seleccionaron investigaciones relevantes que permitieron conocer los compuestos químicos aislados y su actividad biológica. Resultados: Entre los compuestos sintetizados por C. brasiliense destacan calanólidos e inofilums, especialmente el (+)-calanólido A, como inhibidores potentes de la enzima transcriptasa reversa del virus de inmunodeficiencia humana tipo 1 (VIH-1) y baja toxicidad a linfocitos humanos. El (+)-calanólido A, una dipiranocumarina tetracíclica, podría ser el primer fármaco de origen natural aprobado por la FDA (EUA) en el tratamiento del VIH/SIDA. Otros compuestos, tales como cumarinas tipo mammea, cromanonas, xantonas y triterpenos, mostraron actividad contra protozoarios, células tumorales humanas, como bactericidas y antiespasmódicos. La actividad más importante de cumarinas tipo mammea es contra protozoarios como Leishmania y Trypanosoma. En relación a L. amazonensis, destacó (-)-mammea A/BB presentando buena actividad y selectividad contra amastigotes y promastigotes, y baja toxicidad en macrófagos humanos. La (-)-mammea A/BA, y las xantonas preniladas mostraron alta citotoxicidad sobre líneas celulares tumorales humanas y T. cruzi. Las evidencias químicas, anatómicas y genéticas indican que existen quimiotipos en C. brasiliense, sugiriendo un proceso de especiación en curso en el taxón. Las secuencias ribosomales (ITS) discriminaron al quimiotipo 1 (produce coumarinas tipo mammea) de los quimiotipos 2 y 3 (biosintetizan calanólidos e inofilums), siendo útiles como posibles códigos de barras. Conclusiones: El adecuado manejo de C. brasiliense mediante técnicas silvícolas y biotecnológicas, así como el conocimiento científico y tecnológico, podrían aportar soluciones a países en desarrollo, por ejemplo mediante producción de fitomedicamentos, a enfermedades como el VIH/SIDA, Leshmaniasis y la Enfermedad de Chagas
Downloads
References
Patil AD, Freyer AJ, Eggleston DS, Haltiwanger RC, Bean MF, Taylor PB, et al. The inofilums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malasyan tree, Calophyllum inofilum Linn. J Med Chem. 1993 Dec; 36 (26): 4131-4138.
Stevens PF. A revision of the old world species of Calophyllum (Guttiferae). J Arnold Arbor. 1980 Apr; 61 (2): 117-171.
Bisse J. Árboles de Cuba. La Habana (Cuba): Ed. CientíficoTécnica; 1981. 384 p.
García-Barriga H. Flora medicinal de Colombia. Botánica Médica, 2ª Ed. vol. 2. Bogotá (Colombia): Tercer Mundo Editores; 1992. 537 p.
Pennington TD and Sarukhán J. Árboles tropicales de México. 2ª Ed. D.F. (México): Universidad Nacional Autónoma de MéxicoFondo de Cultura Económica; 1998. 521 p.
Rodríguez ME, Cardozo AE, Krauczuk ER, Fontana JL, Iriart D. Calophyllum brasiliense (Clusiaceae): Nuevo registro para la flora de la Argentina. Bol Soc Argent Bot. 2009 Ago-Dic; 44 (3-4): 361-366.
Pereira MOS, Gottlieb OR, Magalhaes MT. Novas xantonas do Calophyllum brasiliense. An Acad Bras Cienc. 1967 Jun; 39 (2): 255-256
Da Silva Pereira MO, Gottlieb OR, Taveira Magalhaes M. Chemistry of brazilian Guttiferae. IX. Xanthone constituents of Calophyllum brasiliense Engl. An Acad Brasil Cienc. 1966; 38: 425-427.
Estrada-Muñiz E. Cumarinas y Xantonas de Calophyllum brasiliense: Evaluación de su actividad antiviral, citotóxica y antibacteriana [master’s thesis]. [D.F., México]: Universidad Nacional Autónoma de México: 2001. 65 p.
Xiao-Hui S, Man-Li Z, Li-Geng L, Chang-Hong H, Yu-Cheng G, Qing-Wen S. Chemical constituents of the plants of the genus Calophyllum. Chem Biodivers. 2008 Dec; 5 (12): 2579-2608.
Downloads
Published
How to Cite
Issue
Section
License
Copyright Notice and Open Access Statement
The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the Creative Commons license, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.
Authors declare that:
-
They are the intellectual property owners and are responsible for all the information stated in the article.
-
This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.
-
They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.
-
They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.
-
Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.
-
They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.
-
They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.
-
They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.
-
After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.
Conflict of interest: Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.
